Notice of Annual General Meeting/Proxy Form
May 2, 2019
Imagion Biosystems has announced “Notice of Annual General Meeting/Proxy Form.” Click here to view the notice (726 KB pdf)
Category: Investor updates
Appendix 4G and Corporate Governance Statement
April 30, 2019
Imagion Biosystems Appendix 4G and Corporate Governance Statement for the financial year ended 31 December 2018 is available. Download Appendix 4G.
Annual Report to Shareholders
April 30, 2019
The Imagion Biosystems Annual Report for the year ended 31 December 2018 is available here. Download the 2018 Annual Report.
Appendix 4C – Quarterly
April 26, 2019
Imagion Biosystems Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B was announced 26th April 2019. Download Appendix 4C for the quarter ended
Imagion Biosystems receives order related to cancer treatment
April 11, 2019
Imagion Biosystems today announced that NewPhase Ltd., an Israeli biotechnology company developing cancer treatments, has issued an extended purchase order to Imagion Biosystems for the
Imagion Biosystems Receives US Patent Related to Treatment of Disease
March 12, 2019
Imagion Biosystems today announced that the U.S. Patent and Trademark Office has issued patent #10194825 B2 for “Methods and Apparatuses for the localization and treatment
Appendix 4E and Preliminary Report for 2018
February 28, 2019
Imagion Biosystems has released “Preliminary Report and Appendix 4E for the year ended 31 December 2018. View Appendix 4E and Preliminary Report.
What's New in Medical Imaging — Radio Interview with Mike Harsh
February 25, 2019
Click play icon ▶️ to listen (transcript follows below): As a sought-after medical imaging industry thought leader, Mike Harsh sat for a recorded interview by
Imagion Biosystems hits key development milestone with initiation of toxicology study
February 20, 2019
Imagion Biosystems has achieved a key milestone in its progress to first-in-human testing with the commencement of a toxicology safety study of its lead nanoparticle
Appendix 4C – quarterly
January 31, 2019
Appendix 4C, “December 2018 Quarterly Update” was lodged with the Australian Securities Exchange on 31st January. View the Appendix 4C.